Spontaneous inhibition of HTL V-I expression in the peripheral blood
Spontaneous inhibition of HTL V-I expression in the peripheral blood
批准号:
06670333
负责人:
KANNAGI Mari
金额:
$0.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Human T-cell leukemia virus type-I (HTLV-I) is associated with adult T cell leukemia (ATL) and HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-I tax is one of the main target antigens recognized by HTLV-I-specific cytotoxic T lymphocytes (CTL). This is advantageous for the host, because cytolysis probably occurs at an early stage of leukemogenesis.Immediate detection of CTL activity in the PBMC is unusual, because virusspecific CTL activity resulting from prior infection can be detected generally only after in vitro restimulation. A similar phenomenon has been noted in humanimmunodeficiency viruus infection, which is believed to reflect active immune stimulation in vivo. The level of HTLV-I expression is elevated in the peripheral blood of HAM/TSP patients. However, the level of HTLV-I gene expression could be spontaneously elevated in vitro. Fresh leukemia cells of ATL patients only marginally expressed HTLV-I mRNA,but showed a significant induction of HTLV-I mRNA and antigens following in vitro incubation in vitro. Such induction was observed in the PBMC of asymptomatic HTLV-I carriers and HAM/TSP patients. This suppression of HTLV-I expression, presumably mediated by a plasma factor and commonly observed in HTLV-I-infected individuals, could be one reason for the persistence of HTLV-I-infection.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kannagi,M.: "Expression of the target antigen for cytotoxic T lymphocytes on adult T cell leukemia cells." Int.J.Cancer. 54. 582-588 (1993)
Kannagi,M.:“细胞毒性 T 淋巴细胞的靶抗原在成人 T 细胞白血病细胞上的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kannagi, M.: "Expression of the target antigen for cytotoxic T lymphocytes on adult T cell leukemia cells." Int. J. Cancer. 54. 582-588 (1993)
Kannagi, M.:“细胞毒性 T 淋巴细胞的靶抗原在成人 T 细胞白血病细胞上的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
EL-Farrash,M.A.: "Isolation of human T-cell leukemia type I from a transformed T-cell line derived spontaneously from lymphocytes of a seronegative Fgyptian patient with mycosis fungoides." Blood. 86. 1842-1849 (1995)
EL-Farrash,M.A.:“从患有蕈样肉芽肿的血清阴性埃及患者的淋巴细胞自发衍生的转化 T 细胞系中分离人类 I 型 T 细胞白血病。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
神奈木 真理: "HTLV-I反応性T細胞の認識ペプチド" 臨床免疫. 26. 412-417 (1994)
Mari Kanagi:“HTLV-I 反应性 T 细胞的识别肽”《临床免疫学》26. 412-417 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
EL-Farrash,M.A.: "Isolation of human T-cell leukemia type I from a transformed T-cell line derived spontaneously from lymphocytes of a seronegative Wgyptian patient with mycosis fungoides." Blood. 86. 1842-1849 (1995)
EL-Farrash,M.A.:“从患有蕈样肉芽肿的血清阴性 Wgyptian 患者的淋巴细胞自发衍生的转化 T 细胞系中分离出人类 I 型 T 细胞白血病。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
Host innate immune mechanisms separating inflammatory or lymphoproliferative diseases in HTLV-1 infection
-
批准号:20K07512
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:KANNAGI Mari
-
依托单位:
Anti-viral immuno therapeutic approaches for adult T-cell leukemia
-
批准号:17013028
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$31.04万
-
财政年份:2005
-
负责人:KANNAGI Mari
-
依托单位:
The mechanism of immune insufficiency against retroviral tumors and its restoration
-
批准号:15023217
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$10.94万
-
财政年份:2003
-
负责人:KANNAGI Mari
-
依托单位:
Role of vertical transmission of HTLV-I on the risk for T cell malignancy
-
批准号:12470052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.91万
-
财政年份:2000
-
负责人:KANNAGI Mari
-
依托单位:
Characterization of the HTLV-I receptor
-
批准号:04670276
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.32万
-
财政年份:1992
-
负责人:KANNAGI Mari
-
依托单位:
海外基金